Acute renal injury: new progress in epidemiology_Chinese Journal of Evidence-Based Medicine

Authors：

CAO Jie ¹ , ZHAO Yuliang ^2,3 ,  FU Ping ^2,3

1. West China Medical School of Sichuan University, Chengdu, 610041, P.R.China;
2. Division of Nephrology, West China Hospital of Sichuan University, Chengdu, 610041, P.R.China;
3. Kidney Research Laboratory, National Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, P.R.China;

Corresponding author：

FU Ping, Email: fupinghx@163.com

Keywords：

Acute kidney injury; Epidemiology; Acute kidney disease

DOI：

10.7507/1672-2531.201812024

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Acute kidney injury (AKI) is characterized by a rapid decrease in renal function caused by different etiologies and can involve multiple organs and systems. AKI is a potentially reversible disease. However, it can also progress to chronic kidney disease (CKD) without proper treatment. The concept of acute kidney disease (AKD) is recently recommended as a derivative between AKI and CKD. At present, AKI still lacks specific drug treatment; therefore prevention and early diagnosis are crucial in AKI management. Due to the heterogeneity of the pathogenesis, the epidemiological features of AKI vary across nations and regions, so the strategies for prevention and control are different. This papers reports new progress of epidemiological features of AKI in different countries, so as to provide reference for assessing the disease burden and formulating public health policies.

Citation： CAO Jie, ZHAO Yuliang, FU Ping. Acute renal injury: new progress in epidemiology. Chinese Journal of Evidence-Based Medicine, 2019, 19(6): 631-634. doi: 10.7507/1672-2531.201812024 Copy

1.	赵宇亮, 张凌, 付平. 脓毒症急性肾损伤发病机制和诊断治疗的新认识. 中华内科杂志, 2014, 53(1): 70-73.
2.	赵宇亮, 张凌, 付平. 提高肾脏病整体预后工作组急性肾损伤临床实践指南热点解读. 中华内科杂志, 2012, 51(12): 935-939.
3.	Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol, 2018, 14(10): 607-625.
4.	Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol, 2017, 13(4): 241-257.
5.	Meersch M, Volmering S, Zarbock A. Prevention of acute kidney injury. Best Pract Res Clin Anaesthesiol, 2017, 31(3): 361-370.
6.	Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol, 2013, 8(9): 1482-1493.
7.	Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey. Lancet, 2015, 386(10002): 1465-1471.
8.	Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in chinese hospitalized adults. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
9.	Selby NM, Crowley L, Fluck RJ, et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol, 2012, 7(4): 533-540.
10.	Siew ED, Deger SM. Recent advances in acute kidney injury epidemiology. Curr Opin Nephrol Hypertens, 2012, 21(3): 309-317.
11.	Yu MY, Lee SW, Baek SH, et al. Hypoalbuminemia at admission predicts the development of acute kidney injury in hospitalized patients: A retrospective cohort study. PLoS One, 2017, 12(7): e0180750.
12.	Lapi F, Azoulay L, Yin H, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ, 2013, 346: e8525.
13.	Yang Y, George KC, Shang WF, et al. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Drug Des Devel Ther, 2017, 11: 1291-1299.
14.	Uchino S, Bellomo R, Bagshaw SM, et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant, 2010, 25(6): 1833-1839.
15.	Silver SA, Long J, Zheng Y, et al. Cost of acute kidney injury in hospitalized patients. J Hosp Med, 2017, 12(2): 70-76.
16.	Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, 2015, 385(9987): 2616-2643.
17.	蒋静, 赵宇亮, 付平. 脓毒症性急性肾损伤与线粒体功能障碍. 肾脏病与透析肾移植杂志, 2018, 27(2): 187-191.
18.	Zhao YL, Zhang L, Yang YY, et al. Resolvin D1 protects lipopolysaccharide-induced acute kidney injury by down-regulating nuclear factor-kappa B signal and inhibiting apoptosis. Chin Med J (Engl), 2016, 129(9): 1100-1107.
19.	Gomez H, Kellum JA, Ronco C. Metabolic reprogramming and tolerance during sepsis-induced AKI. Nat Rev Nephrol, 2017, 13(3): 143-151.

1. 赵宇亮, 张凌, 付平. 脓毒症急性肾损伤发病机制和诊断治疗的新认识. 中华内科杂志, 2014, 53(1): 70-73.
2. 赵宇亮, 张凌, 付平. 提高肾脏病整体预后工作组急性肾损伤临床实践指南热点解读. 中华内科杂志, 2012, 51(12): 935-939.
3. Hoste EAJ, Kellum JA, Selby NM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol, 2018, 14(10): 607-625.
4. Chawla LS, Bellomo R, Bihorac A, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol, 2017, 13(4): 241-257.
5. Meersch M, Volmering S, Zarbock A. Prevention of acute kidney injury. Best Pract Res Clin Anaesthesiol, 2017, 31(3): 361-370.
6. Susantitaphong P, Cruz DN, Cerda J, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol, 2013, 8(9): 1482-1493.
7. Yang L, Xing G, Wang L, et al. Acute kidney injury in China: a cross-sectional survey. Lancet, 2015, 386(10002): 1465-1471.
8. Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in chinese hospitalized adults. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
9. Selby NM, Crowley L, Fluck RJ, et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol, 2012, 7(4): 533-540.
10. Siew ED, Deger SM. Recent advances in acute kidney injury epidemiology. Curr Opin Nephrol Hypertens, 2012, 21(3): 309-317.
11. Yu MY, Lee SW, Baek SH, et al. Hypoalbuminemia at admission predicts the development of acute kidney injury in hospitalized patients: A retrospective cohort study. PLoS One, 2017, 12(7): e0180750.
12. Lapi F, Azoulay L, Yin H, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ, 2013, 346: e8525.
13. Yang Y, George KC, Shang WF, et al. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies. Drug Des Devel Ther, 2017, 11: 1291-1299.
14. Uchino S, Bellomo R, Bagshaw SM, et al. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant, 2010, 25(6): 1833-1839.
15. Silver SA, Long J, Zheng Y, et al. Cost of acute kidney injury in hospitalized patients. J Hosp Med, 2017, 12(2): 70-76.
16. Mehta RL, Cerda J, Burdmann EA, et al. International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet, 2015, 385(9987): 2616-2643.
17. 蒋静, 赵宇亮, 付平. 脓毒症性急性肾损伤与线粒体功能障碍. 肾脏病与透析肾移植杂志, 2018, 27(2): 187-191.
18. Zhao YL, Zhang L, Yang YY, et al. Resolvin D1 protects lipopolysaccharide-induced acute kidney injury by down-regulating nuclear factor-kappa B signal and inhibiting apoptosis. Chin Med J (Engl), 2016, 129(9): 1100-1107.
19. Gomez H, Kellum JA, Ronco C. Metabolic reprogramming and tolerance during sepsis-induced AKI. Nat Rev Nephrol, 2017, 13(3): 143-151.

Next Article
Usage and demand for clinical practice guidelines among Chinese health practitioners

Chinese Journal of Evidence-Based Medicine

Acute renal injury: new progress in epidemiology

Abstract Full text Figures/Tables Video References Cited by

Next Article

Format

Content